Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype.

The Journal of nutrition - 1 Feb 2010

Egert Sarah, Boesch-Saadatmandi Christine, Wolffram Siegfried, Rimbach Gerald, Müller Manfred J

Abstract excerpt

Our objective was to examine the effect of a quercetin supplementation on blood pressure, lipid metabolism, markers of oxidative stress, inflammation, and body composition in an at-risk population of 93 overweight-obese volunteers aged 25-65 y with metabolic syndrome traits in relation to apolipoprotein (apo) E genotype. Participants were randomized to receive 150 mg/d quercetin in a double-blinded,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Cross-Over Studies

Share to Double-Blind Method

Share to Phytotherapy

Share to Plant Extracts

Share to Quercetin

Source

Identifiers

PMID: 20032478
DOI: 10.3945/jn.109.117655

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype.PMID 20032478Read ↗

Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms.Semantic proximity Read ↗

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.Semantic proximity Read ↗

Apolipoprotein E polymorphism – a risk factor for metabolic syndromeSemantic proximity Read ↗

Pharmacogenetics of Apolipoprotein E Gene During Lipid-Lowering Therapy: Lipid Levels and Prevention of Coronary Heart DiseaseSemantic proximity Read ↗

Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly PopulationSemantic proximity Read ↗

Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoproteins.Semantic proximity Read ↗

Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease.Semantic proximity Read ↗

APOE genotype associates with food consumption and body composition to predict dyslipidaemia in Brazilian adults with normal-weight obesity syndrome.Semantic proximity Read ↗

Effects of ezetimibe on lipids and lipoproteins in patients with hypercholesterolemia and different apolipoprotein E genotypes.Semantic proximity Read ↗

Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans.Semantic proximity Read ↗

Statin users without an APOE-epsilon4 allele have increased insulin resistance.Semantic proximity Read ↗

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.